STEALTH BIOTHERAPEUTICS CORP
c/o Intertrust Corporate Services (Cayman) Limited
One Nexus Way
Camana Bay, Grand Cayman
KY1-9005 Cayman Islands
June 13, 2022
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Stealth BioTherapeutics Corp |
| Registration Statement on Form F-1 |
| File No. 333-265423 |
| Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-1 (File No. 333-265423), so that it may become effective at 4:00 p.m., Eastern time, on June 15, 2022, or as soon as practicable thereafter.
|
|
|
Very truly yours,
STEALTH BIOTHERAPEUTICS CORP | ||
|
| |
By: |
| /s/ Irene P. McCarthy |
Name: Title: |
| Irene P. McCarthy Chief Executive Officer |